FELICIA WILLIAMS: Open Payments
NPI 1588961627 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 16 payments from 6 companies in 2025. Trend: 2023 $393 · 2024 $401 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $115 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Novo Nordisk Inc | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $16 |
Products named: VRAYLAR, COBENFY, CAPLYTA, REXULTI, Wegovy, Rybelsus.
Industry payments across CA — which companies pay providers there.
